Pheochromocytomas and paragangliomas are rare types of tumors that are typically found in the abdomen but can occur in any location of the body. An international group of health care professionals developed a consensus statement on how to best manage these tumors when they are caused by variants in the gene succinate dehydrogenase complex subunit D (SDHD).
News
NICHD issues News Releases and Media Advisories to the news media. Spotlight and Research Feature articles explain NICHD research findings and public health issues to the general public. An Item of Interest is a short announcement of relevant information, such as a notable staff change.
Science Update: NIH researchers shed light on symptoms of rare disease
NIH researchers have identified additional symptoms of EPAS1 gain-of-function syndrome, a rare disease resulting in hormone-secreting tumors and an increase in red blood cells.
Science Update: Consensus reached on radiation therapy for patients with rare tumors
Researchers at the National Institutes of Health led an international team to develop consensus guidelines on the appropriate use of a specialized form of radiation therapy for patients with pheochromocytoma and paraganglioma—rare cancers— that have spread.
Selected NICHD Research Advances of 2016
NICHD had a very productive year in 2016. Staff responded quickly to Zika virus and led the effort to develop the NIH Research Plan on Rehabilitation. The following snapshots are examples of the many advances made possible by NICHD this year.
Getting to Know the New NICHD Director
NICHD Director Dr. Diana Bianchi shares some thoughts about joining NICHD.
Rare cancers may masquerade as ADHD in children, NIH researchers suggest
Rare tumors called pheochromocytomas and paragangliomas may cause the same symptoms as attention deficit hyperactivity disorder (ADHD) in children, leading to inappropriate treatment that could worsen their symptoms and potentially endanger their health. That’s the conclusion of a new study by National Institutes of Health researchers who evaluated a group of pediatric patients diagnosed with the tumors.
Picture This: NICHD Support for Neuroscience Research
At the annual meeting of the Society for Neuroscience , held in San Diego, California, from November 9–13, more than 30,000 neuroscientists from around the world will share their latest research results and learn about new advances and opportunities in the field.
NICHD podcast features research on adrenal gland disorders
This month’s NICHD Research Perspectives podcast focuses on adrenal gland disorders and research conducted by NICHD staff at the NIH Clinical Center.
2012 Division of Intramural Research (DIR) Annual Report
With 11 research programs, more than 75 researchers, and more than 1,100 support staff, the NICHD's DIR is among the largest at the NIH. But with good reason—The NICHD's DIR also has one of the broadest research portfolios at the NIH, covering nearly all aspects of human development and reproduction.
New syndrome linked to a somatic HIF2A mutation
A team of NIH researchers, in collaboration with scientists from the University of Utah (Salt Lake City) and Tufts Medical Center (Boston), have identified a new syndrome involving two rare neuroendocrine tumors and a rare blood disease. The syndrome was observed in four female patients who had multiple paraganglioma and somatostatinoma tumors and the blood disease polycythemia.
Scientific Vision: The Next Decade
On December 5, 2012, the NICHD released the Scientific Vision: The Next Decade, the culmination of a collaborative process that began in 2011 to identify the most promising scientific opportunities for the Institute and the research community to pursue over the next decade. The Vision statement was made available during the NICHD’s 50th anniversary colloquium.
NICHD reorganizes extramural program
Alan Guttmacher, M.D., Director of the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) announced a number of changes to streamline the institute’s organizational structure and accelerate the exchange of scientific ideas.
NICHD vision statement now available online
A document charting a research course for the many collaborators who share an interest in promoting the science concerning human development through the life span, child health, women's health, and rehabilitation research is now available online.
Research for a Lifetime: Commemorating the NICHD’s 50th Anniversary
As the Institute marks its golden anniversary, we look back on the NICHD's early years, its scientific accomplishments, and its future.
September NICHD Director's podcast now available
The September 2012 NICHD Research Perspectives, the NICHD’s monthly podcast, is now online. The podcast features discussions of research on how a gene found in a rare cancer increases red blood cell production, the involvement of “dark matter” DNA in the body’s response to day and night cycles, and on cesarean delivery versus labor for preterm infants.
Release of the 2011 Division of Intramural Research (DIR) Annual Report
The newly released 2011 DIR Annual Report reviews the latest basic, clinical, and translational research being pursued by the staff scientists within DIR at the NICHD. Contributing to this effort are 79 tenured and tenure-track investigators and approximately 1,200 administrative and research staff. In 2011, DIR project areas ranged from vaccine development to genomics, from reproduction to regenerative medicine, and from the neurosciences and early human development to biophysics and imaging.
Check Out the 2010 Division of Intramural Research (DIR) Annual Report
The 2010 DIR Annual Report illustrates the impressive accomplishments that result when dozens of PIs, more than 350 trainees, and approximately 1,200 staff all work toward the same goal of improving human health.
New Intramural Report Available
The Division’s research programs address topics ranging from molecular and cellular biology, genetics, and endocrine and genetic disorders, to physical biology, neurosciences, immunology, reproduction, and behavioral research. Its projects are organized around the theme of the orchestration of life by molecular messengers.
BACK TO TOP